1
|
Zhang N, Su T, Yan J, Zhang M, Zhao S, Liu C, Chen T. Case report: Successful immunomodulators combined with electromagnetic field therapy in a patient with methazolamide-induced Steven Johnson syndrome/toxic epidermal necrolysis overlap. Front Med (Lausanne) 2023; 10:1192920. [PMID: 37305125 PMCID: PMC10248229 DOI: 10.3389/fmed.2023.1192920] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2023] [Accepted: 05/09/2023] [Indexed: 06/13/2023] Open
Abstract
Methazolamide is used to treat patients with glaucoma. However, as a sulfonamide derivative, methazolamide shares the same adverse reaction profile as other sulfa-based medications. Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare delayed-type hypersensitivity cutaneous reactions with high morbidity and mortality. Here, we report a severe SJS/TEN overlap syndrome in an 85-year-old Chinese male patient who received methazolamide 25 mg twice daily for his left eye glaucoma. The causal relationship between SJS/TEN and methazolamide was categorized as "highly likely" on the algorithm for assessing drug causality for epidermal necrolysis. In addition to the treatments with methylprednisolone and immunoglobulin, we used a special electromagnetic spectrum therapeutic apparatus to provide skin wound care. The patient had a thoroughly satisfying recovery. This is the first case report to use electromagnetic field therapy in a patient with SJS/TEN. We share our experience here and suggest that electromagnetic field therapy can provide advanced skin wound care and facilitate the recovery of SJS/TEN.
Collapse
Affiliation(s)
- Naiju Zhang
- Department of Pharmacy, First Affiliated Hospital of Bengbu Medical College, Institute of Emergency and Critical Care Medicine, Anhui Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu, Anhui, China
| | - Tianjiao Su
- Key Laboratory of Immunology in Chronic Diseases, Department of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
| | - Jingwen Yan
- Key Laboratory of Immunology in Chronic Diseases, Department of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
| | - Mei Zhang
- Key Laboratory of Immunology in Chronic Diseases, Department of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
| | - Shousong Zhao
- Key Laboratory of Immunology in Chronic Diseases, Department of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
| | - Chuanmiao Liu
- Key Laboratory of Immunology in Chronic Diseases, Department of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
| | - Tianping Chen
- Department of Cardiology, First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
| |
Collapse
|